Featured Research

from universities, journals, and other organizations

Conducting Research During Humanitarian Emergencies

Date:
April 14, 2008
Source:
Public Library of Science
Summary:
In 1987 the international medical and humanitarian aid organization Médecins Sans Frontières (MSF, Doctors without Borders) created its own research center, called Epicentre, to help address critical health research questions that arise during humanitarian emergencies. Now scientists look back over twenty years of research conducted by MSF and Epicentre and discuss how this research helped to improve field operations.

In 1987 the international medical and humanitarian aid organization Médecins Sans Frontières (MSF, Doctors without Borders) created its own research center, called Epicentre, to help address critical health research questions that arise during humanitarian emergencies. In PLoS Medicine, Vincent Brown from Epicentre and colleagues look back over twenty years of research conducted by MSF and Epicentre and discuss how this research helped to improve field operations.

The authors discuss their research on:

  • rapidly assessing the health status of a population--such as a July 1994 survey among 800,000 Rwandan refugees in Goma, Zaïre, which showed that in the first month alone over 10% of the population had died, 88% from diarrhea
  • responding to infectious disease outbreaks, such as a 2004 study during a large hepatitis E outbreak in Darfur, Sudan, which found that chlorinated surface water was a potential risk factor for hepatitis E transmission compared with non-chlorinated water from deep drilling
  • treating malnutrition, including testing various techniques to try and predict acute malnutrition in young children
  • developing better diagnostic tools, such as rapid diagnostic tests for malaria.
  • "Finding pragmatic and efficacious answers to public health questions generated by the field has led Epicentre research activities over the last 20 years," say Dr Brown and colleagues. "The ultimate goal remains to address questions aimed at significantly improve the health status of affected populations."

Journal reference: Brown V, Guerin PJ, Legros D, Paquet C, Pécoul B, et al. (2008) Research in complexhumanitarian emergencies: The Médecins Sans Frontières/Epicentre experience. PLoS Med 5(4): e89.



Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Cite This Page:

Public Library of Science. "Conducting Research During Humanitarian Emergencies." ScienceDaily. ScienceDaily, 14 April 2008. <www.sciencedaily.com/releases/2008/04/080414210306.htm>.
Public Library of Science. (2008, April 14). Conducting Research During Humanitarian Emergencies. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/04/080414210306.htm
Public Library of Science. "Conducting Research During Humanitarian Emergencies." ScienceDaily. www.sciencedaily.com/releases/2008/04/080414210306.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins